ORCID as entered in ROS
https://orcid.org/0000-0002-8533-2957
Scheduled Maintenance Notice
Please note that Researcher Profiles will be undergoing scheduled maintenance on Wednesday 7th Oct, from 8:00am to 9:00am. During this time, the Researcher Profiles system will be unavailable. We apologise for any inconvenience and appreciate your understanding.
Select Publications
Journal articles
, 2021, 'Hepatitis C treatment as prevention in the prison setting: Assessments of acceptability of treatment scale up efforts by prison correctional and health personnel', International Journal of Drug Policy, 98, http://dx.doi.org/10.1016/j.drugpo.2021.103379
, 2021, 'Scaling up sexually transmissible infections point-of-care testing in remote Aboriginal and Torres Strait Islander communities: healthcare workers’ perceptions of the barriers and facilitators', Implementation Science Communications, 2, pp. 127, http://dx.doi.org/10.1186/s43058-021-00232-8
, 2021, 'Self-collection for HPV-based cervical screening: a qualitative evidence meta-synthesis', BMC Public Health, 21, pp. 1503, http://dx.doi.org/10.1186/s12889-021-11554-6
, 2021, 'Associations Between Social Capital and HIV Risk-Taking Behaviors Among Men Who Have Sex with Men in Japan', Archives of Sexual Behavior, 50, pp. 3103 - 3113, http://dx.doi.org/10.1007/s10508-021-02097-3
, 2021, 'Expert stakeholder perspectives on the acceptability of treatment-as-prevention in prison: a qualitative substudy of the ‘Surveillance and Treatment of Prisoners with Hepatitis C’ project (SToP-C)', Addiction, 116, pp. 2761 - 2769, http://dx.doi.org/10.1111/add.15477
, 2021, 'Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs', International Journal of Drug Policy, 96, http://dx.doi.org/10.1016/j.drugpo.2021.103469
, 2021, 'Structural competency in the post-prison period for people who inject drugs: A qualitative case study', International Journal of Drug Policy, 95, http://dx.doi.org/10.1016/j.drugpo.2021.103261
, 2021, 'The role of social capital in facilitating hepatitis C treatment scale-up within a treatment-as-prevention trial in the male prison setting', Addiction, 116, pp. 1162 - 1171, http://dx.doi.org/10.1111/add.15277
, 2020, 'Violence and hepatitis C transmission in prison—A modified social ecological model', Plos One, 15, pp. e0243106, http://dx.doi.org/10.1371/journal.pone.0243106
, 2020, 'Qualitative evidence synthesis on self-collection for human papillomavirus–based cervical screening: Protocol for systematic review', Jmir Research Protocols, 9, http://dx.doi.org/10.2196/21093
, 2020, '‘Behind closed doors, no one sees, no one knows’: hepatitis C, stigma and treatment-as-prevention in prison', Critical Public Health, 30, pp. 130 - 140, http://dx.doi.org/10.1080/09581596.2018.1541225
, 2020, 'Perceptions and concerns of hepatitis C reinfection following prison-wide treatment scale-up: Counterpublic health amid hepatitis C treatment as prevention efforts in the prison setting', International Journal of Drug Policy, 77, http://dx.doi.org/10.1016/j.drugpo.2020.102693
, 2019, '‘Fighting a losing battle’: prisoners’ perspectives of treatment as prevention for hepatitis C with inadequate primary prevention measures', Drugs Education Prevention and Policy, 26, pp. 502 - 507, http://dx.doi.org/10.1080/09687637.2018.1494135
, 2019, 'Developing Attributes and Attribute-Levels for a Discrete-Choice Experiment: An Example for Interventions of Impulsive Violent Offenders.', Applied Health Economics and Health Policy, http://dx.doi.org/10.1007/s40258-019-00484-5
, 2018, 'Understanding facilitators and barriers of direct-acting antiviral therapy for hepatitis C virus infection in prison', Journal of Viral Hepatitis, 25, pp. 1526 - 1532, http://dx.doi.org/10.1111/jvh.12987
, 2018, 'Measuring Social Capital in the Prison Setting: Lessons Learned From the Inmate Social Capital Questionnaire', Journal of Correctional Health Care, 24, pp. 407 - 417, http://dx.doi.org/10.1177/1078345818793141
, 2018, 'A policy analysis exploring hepatitis C risk, prevention, testing, treatment and reinfection within Australia's prisons', Harm Reduction Journal, 15, pp. 39, http://dx.doi.org/10.1186/s12954-018-0246-6
, 2018, 'Changes to home detention in South Australia: Evaluation design and early implementation findings', Advancing Corrections, 5th edition, pp. 34 - 47, https://icpa.org/library/a-preview-of-the-advancing-corrections-journal-edition-5-2018/
, 2018, 'Who goes first? Understanding hepatitis C risk among injecting networks in the prison setting', Drug and Alcohol Dependence, 183, pp. 96 - 101, http://dx.doi.org/10.1016/j.drugalcdep.2017.10.030
, 2017, '‘It's Fast, It's Quick, It Stops Me Being Sick’: How to influence preparation of opioid tablets for injection', Drug and Alcohol Review, 36, pp. 651 - 657, http://dx.doi.org/10.1111/dar.12562
, 2017, 'Social capital strategies to enhance hepatitis C treatment awareness and uptake among men in prison', Journal of Viral Hepatitis, 24, pp. 111 - 116, http://dx.doi.org/10.1111/jvh.12627
, 2016, 'Unlocking dimensions of social capital in the prison setting', Health and Justice, 4, pp. 9, http://dx.doi.org/10.1186/s40352-016-0040-z
, 2016, 'Contextualising the social capital of Australian Aboriginal and non-Aboriginal men in prison', Social Science and Medicine, 167, pp. 29 - 36, http://dx.doi.org/10.1016/j.socscimed.2016.08.040
, 2015, 'Indicators of social capital in prison: a systematic review', Health & Justice, 3, pp. 3 - 7, http://dx.doi.org/10.1186/s40352-015-0020-8
Conference Papers
, 2018, '"I'M JUST STUCK IN THE MUD AT THE MOMENT. REALLY STUCK IN THE MUD": ADVANCING CARE FOR ABORIGINAL CLIENTS OF CLIENTS OF A SUPERVISED INJECTING FACILITY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S15 - S16
, 2018, 'FEAR AND FENCES: IDENTIFYING BARRIERS TO CARE AMONG CLIENTS OF A SUPERVISED INJECTING FACILITY', in DRUG AND ALCOHOL REVIEW, WILEY, pp. S15 - S15
Conference Posters
, 2017, 'Does Australia’s policy landscape support HCV treatment as prevention in the prison setting in the new DAA era?', New Jersey, USA, presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
, 2017, 'Scaling up or holding back? Contemplating treatment as prevention in the prison setting within Australia’s current policy frameworks.', Cairns, Queensland, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, Queensland, 10 August 2017 - 11 August 2017
, 2017, 'Treatment as prevention in the prison setting: Prisoners’ perspectives', presented at Australasian Viral Hepatitis Elimination Conference, 10 August 2017 - 11 August 2017
, 2017, '“Behind closed doors, no one sees, no one knows”: Stigma and treatment as prevention in prison', Cairns, presented at Australasian Viral Hepatitis Elimination Conference, Cairns, 10 August 2017 - 11 August 2017
, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Hawaii, USA, presented at HEP DART 2015, Hawaii, USA, 06 December 2015 - 10 December 2015
, 2015, 'Identifying the social capital of men in prison screening positive for HCV', Sydney, Australia, presented at 4th International Symposium on Hepatitis Care in Substance Users, Sydney, Australia, 07 October 2015 - 09 October 2015
Conference Presentations
, 2024, 'Acceptability of HCV point of care tests in prison settings', presented at 12th International Conference on Health and Hepatitis Care in Substance Users, Athens, Greece, 08 October 2024 - 11 October 2024
, 2024, 'Imagined possibilities of sexual healthcare that meets the needs of sexuality and gender diverse Aboriginal and Torres Strait Islander young people', presented at 25th International Union Against Sexually Transmitted Infections (IUSTI) World Congress, Sydney, Australia, 17 September 2024 - 20 September 2024
, 2024, 'Imagined possibilities of sexual healthcare that meets the needs of sexuality and gender diverse Aboriginal and Torres Strait Islander young people', presented at 25th International Union Against Sexually Transmitted Infections (IUSTI) World Congress, Sydney, Australia, 17 September 2024 - 20 September 2024
, 2023, 'Enablers and barriers to scaling up infectious diseases point-of-care testing in the primary care setting in Australia', presented at Australasian Conference on Point of Care Testing for Infectious Diseases, Sydney, 14 March 2023 - 15 March 2023
, 2022, 'Trust and Service Engagement Among People Who Inject Drugs Post-Release', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Glasgow, Scotland, 19 October 2022 - 21 October 2022
, 2022, 'An evaluation of MyCheck: a digital STI/BBV e-testing platform', presented at ASHM, 29 August 2022 - 01 September 2023
, 2022, 'Client and staff perceptions of acceptability of an alternative telehealth testing pathway at Sydney Sexual Health Centre for bloodborne virus and sexually transmissible infections', presented at Joint Australasian HIV&AIDS and Sexual Health Conferences, Sunshine Coast, 29 August 2022 - 01 September 2022
, 2022, 'The role of point-of-care hepatitis C RNA testing at prison intake for reducing barriers to the hepatitis C care cascade', presented at Australasian Viral Hepatitis Conference, Brisbane, 29 May 2022 - 31 May 2022
, 2021, 'Perceptions and concerns of hepatitis c reinfection in the prison setting', presented at Justice Health Conference, Public Health Association Australia, Virtual (Australia), 03 November 2021 - 04 November 2021
, 2021, 'Correctional Officers and Health Staff Perspectives Of Hepatitis C Treatment As Prevention Scale Up Within The Prison Setting', presented at International Conference on Health and Hepatitis in Substance Users (INHSU), Virtual (International), 13 October 2021 - 15 October 2021
, 2021, 'Scaling Up Hepatitis C Treatment within the Prison Setting: The Role of Social Capital', presented at Academic and Health Policy Conference on Correctional Health (ACCJH), Virtual (USA), 08 April 2021 - 10 April 2021
, 2019, 'Understanding barriers and facilitators to the take up of new DAA hepatitis C treatments', presented at HARP Forum - 2019: The Millennial Edition, Sydney, 16 October 2019 - 17 October 2019
, 2019, 'Injecting culture following prison-wide hepatitis c treatment scale-up: negotiating risk after cure', presented at Australasian Viral Hepatitis Elimination Conference, Sydney, Australia, 05 August 2019 - 06 August 2019
, 2018, 'Reinfection and retreatment: Attitudes among prisoner participants from the Australian SToP-C study', presented at 7th International Symposium on Hepatitis Care in Substance Users, Cascais, Portugal, 19 September 2018 - 21 September 2018
, 2018, 'The Matter of Reinfection: Attitudes among Australian Prisoners from the SToP-C Study', presented at Australasian Viral Hepatitis Conference 2018, Adelaide, 13 August 2018 - 15 August 2018
, 2017, 'Prisoners' perspectives of treatment as prevention for hepatitis C in the prison setting', presented at HEP DART, Hawaii, USA, 03 December 2017 - 07 December 2017
, 2017, 'Treatment as Prevention in the Prison Setting: Prisoners' Perspectives', presented at 6th International Symposium on Hepatitis Care in Substance Users (INHSU), New Jersey, USA, 06 September 2017 - 08 September 2017
, 2016, 'Preparing Prescription Opiates for Injection: Understanding Preferences and Practices', presented at Australasian Professional Society on Alcohol and other Drugs Annual Scientific Conference, Sydney, Australia, 30 October 2016 - 02 November 2016
Filter by type
https://orcid.org/0000-0002-8533-2957